C26H23N7O2
Neat
465.52
Acalabrutinib enantiomer; 1952316-43-6; R-Acalabrutinib; (R)-Acalabrutinib; Acalabrutinib, (R)-; MFCD30530419; 4-[8-amino-3-[(2R)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1, 5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide; CHEMBL4747506; 6J82PAQ862; (R)-4-(8-Amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1, 5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide; C26H23N7O2; Benzamide, 4-(8-amino-3-((2R)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1, 5-a)pyrazin-1-yl)-N-2-pyridinyl-; Benzamide, 4-[8-amino-3-[(2R)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1, 5-a]pyrazin-1-yl]-N-2-pyridinyl-; UNII-6J82PAQ862; orb1741378; SCHEMBL17842601; SCHEMBL30193365; 4-{8-amino-3-[(2R)-1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1 and 5-a]pyrazin-1-yl}-N-(pyridin-2-yl)benzamide; BDBM50557486; AKOS030627655
4-[8-amino-3-[(2R)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1 and 5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide
InChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m1/s1